CDNS heads into its May 7 Q1 results filing with a rare post-earnings tailwind already in place — a cluster of analyst upgrades, a short-seller retreat, and options traders pivoting away from the hedged posture that characterised much of April.
The most striking development this week was the near-unanimous analyst response to Cadence's April 27 earnings release. Every firm that moved kept its constructive rating intact. Wells Fargo raised its target from $375 to $400. Keybanc went furthest at $425, up from $405. Citigroup moved to $400 from $385. Baird and Rosenblatt also lifted targets. Piper Sandler, the lone hold-equivalent on the list, nudged its Neutral target from $319 to $325 — effectively marking current price as fair value. The mean target across the Street now stands at $380, implying roughly 17% upside to Wednesday's close of $325.31. That gap reflects a market that sold off harder than analysts think is warranted.
The bull case centres on Cadence's $7.8 billion backlog — up more than 11% quarter-on-quarter — and full-year revenue growth guidance of 11–13%. With roughly two-thirds of expected FY26 revenues already covered by existing contracts, the revenue-visibility argument is genuine. The bear camp focuses on longer-term structural concerns: EDA growth is seen slowing toward high single digits, IP growth toward low teens, and competitive pressure in both segments is unrelenting. The market's reaction underscores that ambiguity — shares fell 2.3% on the day of the print before stabilising, and are down just 0.2% on the week, suggesting the initial reaction was more an unwind of a defensively positioned book than a fundamental re-assessment.
Options positioning corroborates that read. Defensive hedging has unwound sharply. The put/call ratio dropped to 1.06 by close on April 28 — well below its 20-day average of 1.26, and the lowest since early April when the broad market selloff was driving defensive flows. That shift represents roughly 1.7 standard deviations below the recent mean, the most bullish options posture in the past month. Throughout April 6–17, the PCR ran consistently above 1.3, touching 1.45 at its peak — hedging that was clearly event-driven. That pressure has now cleared.
Short interest tells a parallel story of positioning reset. At 2.3% of the free float, CDNS is not a heavily shorted stock. But the intra-month pattern is notable: SI climbed from around 2.3% to a peak of roughly 2.6% in the April 13–22 window — a pre-earnings build — then collapsed back to 2.26% by April 24 as the print approached. The borrow market remains very loose. Cost to borrow has edged up 60% on the week to 0.49%, but in absolute terms that is still near-zero, and availability is ample. The ORTEX short score of 31.8 is well into the lower half of the universe, confirming this is not a squeeze-pressure setup.
The most meaningful insider transaction in the recent window was CFO John Wall's April 16 sale of 21,500 shares at $309.45, valued at approximately $6.7 million. That came after a separate $1.2 million sale in March and a stock award cycle for the CEO and senior leadership team in mid-March. Taken together, the 90-day net insider figure — awards included — is positive, but the CFO's two open-market sales are worth noting as context for the price appreciation since then. Institutionally, the register is orthodox: Vanguard and BlackRock together hold close to 20%. JP Morgan Asset Management added 680,000 shares in Q1, one of the more active additions among top holders.
The next confirmed event to watch is the May 7 analyst day or Q1 call detail. The stock enters that window trading at a P/E of 38.7x and EV/EBITDA of 28.9x — multiples that have expanded roughly 6 points on the P/E line over the past month, reflecting the price recovery but also the Street's revised earnings trajectory. Closest peer SNPS fell 2.9% on Tuesday and is up 3.5% on the week — a slightly more resilient trajectory that the market will likely use as a benchmark for how CDNS's re-rating holds.
See the live data behind this article on ORTEX.
Open CDNS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
